From: Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort
Inclusion criteria | Early-onset preeclampsia n = 6 | Late-onset preeclampsia n = 21 | Women with risk factors n = 26 |
---|---|---|---|
Complications in previous pregnancies: | |||
Preeclampsia | 1 (17%) | 11 (55%) | 10 (38%) |
(Blood pressure ≥ 140 systolic and/or ≥ 90 mmHg diastolic in two consecutive measurements and proteinuria ≥0.3 g/in 24-hour urine collection or two random urine containing ≥ 1+ by dipstick or one dipstick demonstrating ≥ 2+ protein) | |||
Fetal growth restriction | 3 (50%) | 0 (0%) | 5 (19%) |
(Birthweight SD score < −2 standard deviations (SD) according to the Finnish standards*) | |||
Fetal death | - | 1 (5%) | - |
(>22 weeks of gestation or over 500 g) | |||
A history of one of the following conditions: | |||
Obesity | 2 (33%) | 11 (55%) | 11 (42%) |
(BMI over 30 kg/m3 prior to pregnancy) | |||
Gestational diabetes | - | 3 (15%) | 3 (12%) |
(one or more abnormal values in the oral glucose tolerance test) | |||
Chronic hypertension | - | 4 (20%) | 3 (12%) |
(≥140/90 mmHg or medication for hypertension before 20th weeks of gestation) | |||
Age over 40 years | - | 1 (5%) | 1 (4%) |
Age under 20 years | - | - | 1 (4%) |